A cost comparison of infertility treatment for clomiphene resistant polycystic ovary syndrome

Abstract

For a group of obese women with clomiphene resistant polycystic ovary syndrome, in vitro fertilization seems a cost-effective treatment.

An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome

“…Based on these data, we estimated the direct medical costs per term pregnancy including treatment and delivery costs for a woman allocated to rFSH to be e14 489. These costs are comparable to those previously found on ovulation induction with FSH in clomiphene citrate-resistant women with PCOS (Fridstrom et al, 1999). The estimated direct medical cost per term pregnancy including treatment and delivery costs for a woman allocated to the electrocautery strategy was e11 301, which is 22% lower than in women allocated to rFSH treatment.…”